You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
13 August 2009
Original-Research: Merck KGaA (von GBC AG):
24 June 2024
Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued
23 May 2024
21 May 2024
16 May 2024
27 March 2024
Merck KGaA: Dr. Matthias Heinzel, buy
Merck KGaA: Peter Guenter, buy
01
Aug 24
Publication half-yearly financial report
14
Nov 24
Publication quarterly financial report (call-date Q3)
15 May 2024
Q1 statement / Q1 financial report 2024
30 April 2024
Annual financial report 2023
22 November 2023
Q3 statement / Q3 financial report 2023
